The federal agency finally breaks out some information on what it might take to get generic biological drugs approved.
The Scientist
Most Recent
Current and former employees of the US Food and Drug Administration have filed suit, alleging that their employer spied on them for whistleblowing.
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.
After a lightning-fast approval, the first medicine to treat an underlying cause of the disorder hits the market.
Breast implants leaking contaminated silicone are causing a fuss in Europe, but all breast implants carry risks.
The FDA approved 30 drugs last year, the highest number in the last 7 years.
The agency has limited the use of antibiotics in farm animals.
A new study finds that important drug safety data are not seeing the light of day.
The agency releases draft guidelines on unsolicited questions about off-label use, but leaves many questions about social media marketing unanswered.
Despite scientific evidence that Plan B emergency contraception is safe for women of all ages, the department of Health and Human Services declined to approve it for over-the-counter use.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
